首页 | 本学科首页   官方微博 | 高级检索  
     

抗纤胶囊治疗慢性乙型肝炎对肝纤维化指标的影响
引用本文:吴亚平,张士红. 抗纤胶囊治疗慢性乙型肝炎对肝纤维化指标的影响[J]. 医学理论与实践, 2004, 17(10): 1131-1132
作者姓名:吴亚平  张士红
作者单位:江苏省淮安市第四人民医院,223300
摘    要:目的 :观察抗纤胶囊对慢性乙型肝炎病人肝纤维化的影响。方法 :选择慢性乙型肝炎患者 6 0例 ,随机分为治疗组 30例 ,对照组 30例 ,对照组采用常规保肝降酶治疗 ,治疗组在常规保肝降酶基础上给予抗纤胶囊。疗程 3月。治疗前、后分别检测肝纤维化血清学指标HA、LN、PCⅢ、C -Ⅳ。结果 :治疗组各肝纤维化血清学指标明显下降 ,与对照组比较差异有显著性意义 (P <0 0 5 )。结论 :抗纤胶囊可以减轻和抑制慢性乙型肝炎病人肝纤维化

关 键 词:抗纤胶囊  肝纤维化  慢性乙型肝炎
修稿时间:2004-03-30

Influence of Anti-Fibrosis Capsule on Hepatic Fibrosis Markers in Patients with Chronic Hepatitis B
WU Yaping,ZHANG Shihong. Huai' an Fourth People's Hospital,Jiangsu Province. Influence of Anti-Fibrosis Capsule on Hepatic Fibrosis Markers in Patients with Chronic Hepatitis B[J]. The Journal of Medical Theory and Practice, 2004, 17(10): 1131-1132
Authors:WU Yaping  ZHANG Shihong. Huai' an Fourth People's Hospital  Jiangsu Province
Affiliation:WU Yaping,ZHANG Shihong. Huai' an Fourth People's Hospital,Jiangsu Province,223300
Abstract:Objective: To observe influences of anti- fibrosis capsule on hepatic fibrosis in patients with chronic hepatitis B. Methods: Sixty patients with chronic hepatitis B were randomly divided into treatment group and control group. The control group was regularly treated with drugs for maintaining liver and reducing enzyme.and the treatment group was given the anti- fibrosis capsules on the base of regularly maintaining liver and reducing enzyme, Both lasted three months. Before and after treatment, serum markers of hepatic fibrosis (HA, LN, PCⅢ, C-IV) were determined respectively. Results: Serum markers of hepatic fibrosis in the treatment group dropped much, comparing those of the treatment group,and the difference had prominent significance ( P <0.05). Conclusion: The anti- fibrosis capsule can reduce and resist fibrosis of liver in patients with chronic hepatitis B.
Keywords:Anti-fibrosis capsule   Hepatic fibrosis  Chronic Hepatitis B
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号